International Markets and Haemonetics (HAE): A Deep Dive for InvestorsZacks Investment Research • Monday
Haemonetics Corporation (HAE) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 11/05/26
Haemonetics Corporation Announces Second Quarter Fiscal 2027 Financial Results Available on Investor Relations WebsitePRNewsWire • 11/05/26
All You Need to Know About Haemonetics (HAE) Rating Upgrade to BuyZacks Investment Research • 10/27/26
4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch NowZacks Investment Research • 10/20/26
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?Zacks Investment Research • 10/09/26
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026PRNewsWire • 09/30/26
Haemonetics (HAE) is a Top-Ranked Momentum Stock: Should You Buy?Zacks Investment Research • 09/24/26
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by HaemoneticsGlobeNewsWire • 09/15/26